Weight gain has been a losing battle for Americans for decades. Today, more than 70% of Americans are overweight or obese. Most Americans are trying to lose weight at any given time, mostly through diet and exercise. Despite this, obesity and overweight rates keep going up.
Approved by the Food and Drug Administration (FDA) for the treatment of type 2 diabetes, recent studies have found Semaglutide helps with medical weight loss and treats obesity.

Semaglutide is a game-changing drug. Known as Wegovy and Ozempic, Semaglutide helps your pancreas release insulin to lower your blood sugar levels by interacting with glucagon-like peptide-1 receptors. This is done by activating a protein inside your pancreatic beta cells that regulates blood sugar. If you’ve tried to lose weight without success, Semaglutide may help you slim down and keep it off.
Semaglutide is given as a weekly injection and may be used as part of an ongoing weight management plan. It works through the glucagon-like peptide-1 (GLP-1) pathway, which helps regulate hunger, digestion, and blood glucose levels. GLP-1 belongs to a group of hormones known as incretins, which are released from the small intestine after eating. These hormones help control blood sugar by stimulating insulin release and reducing signals that increase glucose production.
Semaglutide may support weight reduction by delaying stomach emptying, which can help you stay satisfied for longer after eating. Its effects on hunger and satiety may make it easier to consume fewer calories throughout the day. When combined with an appropriate weight management program, some people may experience gradual weight loss over time, though individual results can vary.
Semaglutide is delivered by injection into the fatty tissue beneath the skin, with the abdomen being one possible injection site. The medication is typically taken once every seven days, preferably on a consistent day each week, and may be administered at any hour regardless of meals. When combined with a structured program that includes nutrition, lifestyle, and weight management support, Semaglutide may assist patients in achieving their weight loss goals.

Clinical trials showed that people who took Semaglutide over 6 to 8 weeks lost 15% of their body weight.
Schedule a free consultation with our team at InShapeMD – San Angelo today by calling us at (325) 227-4981, scheduling an appointment online, or swing by our office on your way home from work or during your lunch break at 3270 Sherwood Way, San Angelo, TX 76901 (Located inside Any Lab Test Now).
Follow our social media accounts on Facebook, Instagram, and Twitter to stay up to date with new specials, promotions, and products at InShapeMD – San Angelo.